Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su NRX Pharmaceuticals Inc (NASDAQ:NRXP) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 759.57K a 915.88K. Questo rappresenta il 4.17% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in NRX Pharmaceuticals Corp (XNAS:NRXP) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 405.02K azioni scambiate al giorno, ci vorrebbero 2.26 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
915.88K
Vendite allo scoperto %
4.17%
Giorni di copertura
2.26
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
NRXP | NRX Pharmaceuticals, Inc. Comm | 10/15/2025 | 10/24/2025 | 4.17% | 21,987,336 | 915,877 | 405,023 | 2.26 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 09/30/2025 | 10/09/2025 | 3.45% | 21,987,336 | 759,569 | 400,062 | 1.9 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 09/15/2025 | 09/24/2025 | 3.09% | 21,987,336 | 679,818 | 519,728 | 1.31 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 08/29/2025 | 09/10/2025 | 2.88% | 21,987,336 | 632,714 | 548,090 | 1.15 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 08/15/2025 | 08/26/2025 | 2.48% | 21,987,336 | 545,481 | 407,355 | 1.34 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 07/31/2025 | 08/11/2025 | 3.47% | 17,720,848 | 614,859 | 140,271 | 4.38 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 07/15/2025 | 07/24/2025 | 4.51% | 17,720,848 | 799,531 | 146,410 | 5.46 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 06/30/2025 | 07/10/2025 | 5.09% | 17,720,848 | 901,880 | 239,603 | 3.76 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 06/13/2025 | 06/25/2025 | 7.72% | 15,506,627 | 1,196,888 | 368,470 | 3.25 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 05/30/2025 | 06/10/2025 | 7.18% | 15,506,627 | 1,113,105 | 384,400 | 2.9 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 05/15/2025 | 05/27/2025 | 7.17% | 15,506,627 | 1,111,671 | 333,120 | 3.34 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 04/30/2025 | 05/09/2025 | 7.85% | 15,442,364 | 1,212,742 | 85,063 | 14.26 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 04/15/2025 | 04/25/2025 | 8.27% | 15,043,302 | 1,244,321 | 149,028 | 8.35 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 03/31/2025 | 04/09/2025 | 8.66% | 15,043,302 | 1,302,116 | 215,897 | 6.03 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 03/14/2025 | 03/25/2025 | 6.81% | 15,043,302 | 1,025,086 | 180,767 | 5.67 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 02/28/2025 | 03/11/2025 | 7.78% | 15,043,302 | 1,169,750 | 257,721 | 4.54 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 02/14/2025 | 02/26/2025 | 7.65% | 15,043,302 | 1,151,255 | 363,496 | 3.17 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 01/31/2025 | 02/11/2025 | 6.86% | 15,043,302 | 1,032,474 | 779,014 | 1.33 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 01/15/2025 | 01/27/2025 | 11.81% | 10,221,749 | 1,206,825 | 3,907,966 | 1 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 12/31/2024 | 01/10/2025 | 6.29% | 10,221,749 | 643,000 | 1,901,924 | 1 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 12/13/2024 | 12/24/2024 | 5.87% | 10,221,749 | 599,835 | 188,295 | 3.19 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 11/29/2024 | 12/10/2024 | 5.54% | 10,221,749 | 565,801 | 207,283 | 2.73 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 11/15/2024 | 11/26/2024 | 6.53% | 10,221,749 | 667,005 | 113,040 | 5.9 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 10/31/2024 | 11/11/2024 | 7.61% | 8,968,690 | 682,658 | 194,291 | 3.51 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 10/15/2024 | 10/24/2024 | 6.32% | 8,968,690 | 566,989 | 86,556 | 6.55 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 09/30/2024 | 10/09/2024 | 5.93% | 8,968,690 | 532,088 | 65,292 | 8.15 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 09/13/2024 | 09/24/2024 | 4.76% | 8,968,690 | 426,489 | 124,862 | 3.42 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 08/30/2024 | 09/11/2024 | 5.59% | 8,968,690 | 500,987 | 93,481 | 5.36 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 07/31/2024 | 08/09/2024 | 3.83% | 8,774,606 | 336,006 | 49,917 | 6.73 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 07/15/2024 | 07/24/2024 | 3.36% | 8,774,606 | 295,149 | 72,022 | 4.1 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 06/28/2024 | 07/10/2024 | 3.44% | 8,774,606 | 301,666 | 81,790 | 3.69 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 06/14/2024 | 06/26/2024 | 4.07% | 8,774,606 | 357,212 | 135,265 | 2.64 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 05/31/2024 | 06/11/2024 | 3.60% | 8,774,606 | 316,181 | 247,443 | 1.28 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 05/15/2024 | 05/24/2024 | 5.56% | 8,774,606 | 487,879 | 1,212,225 | 1 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 04/30/2024 | 05/09/2024 | 5.63% | 8,629,402 | 486,173 | 314,866 | 1.54 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 04/15/2024 | 04/24/2024 | 6.66% | 7,669,499 | 510,829 | 276,909 | 1.84 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 03/28/2024 | 04/09/2024 | 62.88% | 6,751,410 | 4,245,422 | 1,383,565 | 3.07 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 03/15/2024 | 03/26/2024 | 5.78% | 64,239,901 | 3,714,434 | 3,912,491 | 1 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 02/29/2024 | 03/11/2024 | 4.23% | 64,239,901 | 2,714,361 | 1,582,128 | 1.72 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 02/15/2024 | 02/27/2024 | 6.60% | 58,573,438 | 3,868,244 | 926,194 | 4.18 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 01/31/2024 | 02/09/2024 | 5.04% | 57,065,337 | 2,874,157 | 514,366 | 5.59 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 01/12/2024 | 01/24/2024 | 5.12% | 57,065,337 | 2,920,794 | 534,603 | 5.46 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 12/29/2023 | 01/10/2024 | 4.70% | 57,065,337 | 2,681,775 | 3,649,831 | 1 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 12/15/2023 | 12/27/2023 | 2.34% | 57,065,337 | 1,334,683 | 234,746 | 5.69 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 11/30/2023 | 12/11/2023 | 2.58% | 57,065,337 | 1,471,556 | 278,367 | 5.29 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 11/15/2023 | 11/27/2023 | 2.69% | 57,065,337 | 1,536,934 | 359,355 | 4.28 | |
NRXP | NRX Pharmaceuticals, Inc. Comm | 10/31/2023 | 11/09/2023 | 2.85% | 54,907,266 | 1,565,158 | 379,921 | 4.12 |
In cerca di azioni più vendute allo scoperto?